首页> 外国专利> METHOD OF OBTAINING NOVEL DERIVATIVES OF SPIRO-INDENE OR SPIRO-1,2-DIHYDRO-NAPHTALENE

METHOD OF OBTAINING NOVEL DERIVATIVES OF SPIRO-INDENE OR SPIRO-1,2-DIHYDRO-NAPHTALENE

机译:获得螺-茚或螺-1,2-二氢萘的新型衍生物的方法

摘要

Spiro-oxazolidinones, -thiazolidinones and -imidazolidinones of the formula CHEM or a pharmaceutically acceptable salt thereof, wherein: U is oxygen, sulfur or nitrogen substituted with hydrogen; X is hydrogen or alkyl having 1 to 4 carbon atoms; n is 0 or 1; Y is hydrogen, halo, nitro, trifluoromethyl, hydroxy, alkoxy or alkylthio having 1 to 4 carbon atoms or alkyl having 1 to 4 carbon atoms; and Z is hydrogon, halo, nitro, trifluoromethyl, hydroxy, alkoxy having 1 to 4 carbon atoms or alkyl having 1 to 4 carbon atoms, with the proviso that if either Y or Z is nitro the other is hydrogen, are disclosed which are useful as aldose reductase inhibitors and as therapeutic agents for the treatment of complications arising from diabetes. Pharmaceutical compositions containing the spiro compounds and a method of treating diabetic complications are also disclosed.
机译:的螺-恶唑烷酮,-噻唑烷酮和-咪唑烷酮或其药学上可接受的盐,其中:U是被氢取代的氧,硫或氮; X是氢或具有1-4个碳原子的烷基; n为0或1; Y是具有1-4个碳原子的氢,卤素,硝基,三氟甲基,羟基,烷氧基或烷硫基或具有1-4个碳原子的烷基;并且公开了有用的前提是,Z是具有1-4个碳原子的氢,卤素,硝基,三氟甲基,羟基,烷氧基或具有1-4个碳原子的烷基,但前提是如果Y或Z是硝基,则另一个是氢。作为醛糖还原酶抑制剂和治疗糖尿病并发症的治疗剂。还公开了含有螺化合物的药物组合物和治疗糖尿病并发症的方法。

著录项

  • 公开/公告号PL252487A1

    专利类型

  • 公开/公告日1985-10-08

    原文格式PDF

  • 申请/专利权人 PFIZER;

    申请/专利号PL19850252487

  • 发明设计人

    申请日1985-03-21

  • 分类号C07D;

  • 国家 PL

  • 入库时间 2022-08-22 08:13:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号